0001104659-24-022540.txt : 20240213
0001104659-24-022540.hdr.sgml : 20240213
20240213205020
ACCESSION NUMBER: 0001104659-24-022540
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240209
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Hunter C
CENTRAL INDEX KEY: 0001636385
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38223
FILM NUMBER: 24631484
MAIL ADDRESS:
STREET 1: C/O GENESEE & WYOMING INC.
STREET 2: 20 WEST AVENUE
CITY: DARIEN
STATE: CT
ZIP: 06820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001649904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 462159271
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-264-4280
MAIL ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: RHYTHM METABOLIC, INC.
DATE OF NAME CHANGE: 20150803
4
1
tm246165-5_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-09
0
0001649904
RHYTHM PHARMACEUTICALS, INC.
RYTM
0001636385
Smith Hunter C
C/O RHYTHM PHARMACEUTICALS, INC.
222 BERKELEY STREET, 12TH FLOOR
BOSTON
MA
02116
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-02-09
4
M
0
4063
A
79278
D
Common Stock
2024-02-11
4
M
0
2344
A
81622
D
Common Stock
2024-02-12
4
S
0
1209
51.38
D
80413
D
Common Stock
2024-02-13
4
S
0
709
49.82
D
79704
D
Restricted Stock Units
2024-02-09
4
M
0
4063
0
D
Common Stock
4063
8124
D
Restricted Stock Units
2024-02-11
4
M
0
2344
0
D
Common Stock
2344
2343
D
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.
The restricted stock units vest or have vested as to 25% of the total shares on each of February 11 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.
/s/ Hunter C. Smith
2024-02-13